Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Journey
Companies On The Road
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Journey
Companies On The Road
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
Nice Insight Reports
2022 Sterile
2023 Cell & Gene Therapy
2023 mAb and Recombinant Protein
2024 API
2024 OSD
2024 ADC
2024 mRNA
2024 Mammalian Cell Culture
2024 Microbial Cell Culture
2024 Plasmids
2024 Gene Therapy
2024 Cell Therapy
2024 Sterile
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
CDMO (5)
671 Articles Available
5
28
Can't find what you're looking for? Try our
advanced search
.
Expansion
New Facilities Help AGC Biologics Discover What's Possible
PAO-03-22-R250-16
Drug Product
Contract Manufacturing at the Leading Edge of Process Innovation
PAO-03-22-R250-10
Sterile
Sterile Injectables Device and Packaging Trends
PAO-02-022-NI-01
Oncolytic Viruses
Best Practices For Oncolytic Virus Design, Development, and Manufacturing
PAO-02-022-CL-17
Automation
Innovating in Automation and Data Management to Advance Microbiology
PAO-03-22-R250-06
Drug Delivery
Achieving Long-Term Implantable Drug Delivery
PAO-03-22-R250-04
Investment
Focusing on the Potential of Midsized Pharma Service Organizations
PAO-03-22-R250-03
Scale-Up Collaboration
IDT Biologika Collaborates with Exothera to Push Forward the Scale-Up of Viral Vaccines
PR-M03-22-01
Inhalation
Integrating Development and Manufacturing Experience with Inhalation Solutions
PAO-03-22-R250-02
Private Equity
Supporting Growth for Middle-Market Companies
PAO-02-22-R250-22
Biopharmaceutical Manufacturing
Investing and Expanding for High-Quality Biopharmaceuticals
PAO-02-22-R250-19
Program Launch
Abzena, Alira Health, and Oncodesign Launch DRIVE™-Biologics To Support Access to Specialist Services From Discovery to Clinical Development for Oncology and Inflammation
PR-M02-22-22
Facility Acquisition
MilliporeSigma Announces Closing of Exelead Acquisition and Plans to Invest More Than € 500 Million in Technology Scale-Up
PR-M02-22-20
CDMO Acquisition
Vibalogics Acquired by Top Global CDMO Recipharm AB
PR-M02-22-18
CDMO Acquisition
Recipharm Acquires Arranta Bio, a CDMO Leader in Advanced Therapy Medicinal Products (ATMPs), to Expand its Biologics Offering in the U.S.
PR-M02-22-17
CDMO
Looking to Another 50 Years of Growth
PAO-02-22-R250-01
Animal Health
Leveraging Broad Capabilities in the Growing Animal Health Market
PAO-02-22-R250-09
Parenteral Drug Delivery
Innovating at the Forefront of mRNA LNP Therapies
PAO-02-22-R250-08
COVID-19 Vaccine
AGC Biologics Supports Omicron-Based Vaccine Candidate Manufacturing with Starting Material
PR-M02-22-07
M&A
TriRx Completes Acquisition of Elanco Manufacturing Facility in Speke, United Kingdom
PR-M02-22-06
Facility Expansion
Strengthening Onshore Manufacturing Capabilities Over the Pandemic
PAO-02-22-R250-06
Business Development
MilliporeSigma Announces Organizational Transformation to Strengthen CDMO Offering and Accelerate Future Growth
PR-M02-22-03
Drug Development
Advancing Drug Development with Emerging Technologies
PAO-02-22-R250-03
Parenteral Manufacturing
Staying Ahead of Trends in Small-Volume Parenteral Manufacturing
PAO-01-22-R250-08
«
5
28
»
.svg)
